#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    VEXAS syndrome B-cell lymphoma recurrent Follicle centre lymphoma follicular grade I II – III refractory Neuroblastoma recurrent Familial haemophagocytic lymphohistiocytosis Pancreatic carcinoma Pyoderma gangrenosum Haemolytic uraemic syndrome Fontan procedure Hypersomnia Salivary gland cancer Thromboangiitis obliterans Hepatocellular carcinoma Burkitt's lymphoma Thrombotic thrombocytopenic purpura More trials…

    Learn about Rare Diseases

    Adrenogenital syndrome – Life with Disease Bronchiolitis obliterans syndrome – Life with Disease Nephroblastoma – Trials in Disease Alagille syndrome – Basic Information Cystic fibrosis – Life with Disease Burkitt’s lymphoma – Trials in Disease Leukoencephalopathy – Treatment Lysosomal storage disorder – Diagnostics Andersen-Tawil syndrome – Treatment Osteosarcoma recurrent – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Oxcarbazepine Emapalumab Pyridoxine Peginterferon Alfa-2A Bi 3720931 Amantadine Hemisulfate Camlipixant Pegunigalsidase Alfa FLUCLOXACILLIN SODIUM Odevixibat Sacituzumab Govitecan Iron Sucrose AZD6234 Ipilimumab Sodium Phosphate Dodecahydrate Ceritinib Glipizide SRSD107 Ovolecithin Hydrocortisone Hemisuccinate More therapies…

    Learn about Your Condition

    Micrographic skin surgery Colitis ulcerative Primary biliary cholangitis T-cell lymphoma Pulmonary vascular disorder Post-acute COVID-19 syndrome Laparoscopic surgery Urticaria chronic Heparin resistance Cystic fibrosis lung Oral herpes Ebola disease Colorectal cancer metastatic Transferrin decreased Thymic carcinoma More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Subarachnoid haemorrhage

  • Study on the Effectiveness of Lidocaine Hydrochloride and Sodium Chloride for Treating Headaches in Patients with Spontaneous Brain Bleeding

    Recruiting

    2 1 1
    Investigated Diseases:
    • Subarachnoid haemorrhage
    Investigated Drugs:
    • Lidocaine Hydrochloride
    • Sodium Chloride
    Spain

  • Study of cilostazol and nimodipine combination to improve outcomes in patients with aneurysmal subarachnoid hemorrhage

    Recruiting

    3 1 1
    Investigated Diseases:
    • Subarachnoid haemorrhage
    Investigated Drugs:
    • CILOSTAZOL
    France

  • Study on the Safety and Effectiveness of C1 Esterase Inhibitor and Sodium Chloride for Patients with Aneurysmal Subarachnoid Hemorrhage

    Recruiting

    2 1 1
    Investigated Diseases:
    • Subarachnoid haemorrhage
    Investigated Drugs:
    • C1 Esterase Inhibitor (Human)
    • Sodium Chloride
    The Netherlands

  • Study on the Safety and Effectiveness of Parecoxib and Sodium Chloride for Patients Hospitalized with Spontaneous Subarachnoid Hemorrhage

    Recruiting

    2 1 1
    Investigated Diseases:
    • Subarachnoid haemorrhage
    Investigated Drugs:
    • PARECOXIB
    • Sodium Chloride
    Czechia

  • Study on Deferoxamine for Patients with Aneurysmal Subarachnoid Hemorrhage

    Recruiting

    1 1 1
    Investigated Diseases:
    • Subarachnoid haemorrhage
    Investigated Drugs:
    • Deferoxamine Mesilate
    The Netherlands

  • Study on the Effectiveness of Sphenopalatine Block for Headache Relief in Patients with Subarachnoid Hemorrhage Using Lidocaine Hydrochloride

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • Nefopam Hydrochloride
    • Morphine Hydrochloride
    • Lidocaine Hydrochloride
    France
1 2 3
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!